Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02395198
What this trial is testing

Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients

Who this might be right for
Hepatitis C
Prof. Dr. med. Jens Reimer 2,467
Not applicableEnded earlyNCT04499651
What this trial is testing

Testing of a Navigation Intervention for Hepatitis C and HIV

Who this might be right for
HIV (Human Immunodeficiency Virus)Hepatitis C
University of California, Los Angeles 1
Testing effectiveness (Phase 2)Study completedNCT01265511
What this trial is testing

Study of SCY-635, Pegasys and Copegus in Hepatitis C

Who this might be right for
Hepatitis C Infection
Scynexis, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT02994056
What this trial is testing

Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 32
Not applicableStudy completedNCT00723931
What this trial is testing

PegIntron Injection Surveillance Plan (Study P04123)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 1,267
Post-approval studies (Phase 4)WithdrawnNCT00782301
What this trial is testing

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Who this might be right for
Hepatitis BHuman Immunodeficiency VirusHepatitis C, Chronic
ViiV Healthcare
Large-scale testing (Phase 3)Study completedNCT01851330
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 647
Very early researchActive Not RecruitingNCT03112044
What this trial is testing

Lung Transplant HCV, Pilot Study

Who this might be right for
Lung Transplant InfectionHepatitis C
University Health Network, Toronto 26
Post-approval studies (Phase 4)Study completedNCT01841775
What this trial is testing

Interferon α 2b Pharmacovigilance Study

Who this might be right for
Hepatitis C, Chronic
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 85
Early research (Phase 1)Study completedNCT01525628
What this trial is testing

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 72
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Not applicableStudy completedNCT03341871
What this trial is testing

Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 1,095
Testing effectiveness (Phase 2)Study completedNCT00863239
What this trial is testing

Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Who this might be right for
Hepatitis C, Chronic
Biolex Therapeutics, Inc. 116
Not applicableStudy completedNCT02562742
What this trial is testing

Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Gilead Sciences 554
Large-scale testing (Phase 3)Study completedNCT02651194
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 104
Not applicableStudy completedNCT04137094
What this trial is testing

Development and Pilot Testing of a PHCI for Emergency Department Patients Who Decline Rapid HIV/ HCV Screening

Who this might be right for
HivHepatitis C
Rhode Island Hospital 200
Not applicableStudy completedNCT01667081
What this trial is testing

Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 2,438
Post-approval studies (Phase 4)Study completedNCT01222611
What this trial is testing

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Who this might be right for
Chronic HIV InfectionHCV Coinfection
Fundacion SEIMC-GESIDA 42
Not applicableLooking for participantsNCT07122219
What this trial is testing

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

Who this might be right for
HIVHepatitis C Virus (HCV)
McGill University Health Centre/Research Institute of the McGill University Health Centre 548
Not applicableStudy completedNCT02113865
What this trial is testing

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Who this might be right for
Acquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Next Page